Natthaya Chuaypen Selected Research

Natthaya Chuaypen Research Topics

Disease

17	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2015
15	Chronic Hepatitis B 07/2022 - 01/2015
10	Neoplasms (Cancer) 11/2023 - 01/2015
9	Infections 01/2023 - 01/2019
5	Hepatitis B 11/2023 - 01/2015
4	Dysbiosis 12/2024 - 10/2021
4	Coinfection 07/2023 - 01/2015
4	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 10/2018
3	Non-alcoholic Fatty Liver Disease 02/2024 - 07/2022
3	Fibrosis (Cirrhosis) 01/2022 - 05/2021
3	HIV Infections (HIV Infection) 10/2021 - 01/2020
2	Hepatitis C 11/2023 - 01/2022
2	Liver Diseases (Liver Disease) 11/2023 - 01/2021
2	Urolithiasis 12/2022 - 09/2021
2	Liver Neoplasms (Liver Cancer) 01/2022 - 10/2018
2	Leptospirosis 01/2021 - 11/2020
1	Birth Weight (Birth Weights) 03/2024
1	Chronic Renal Insufficiency 07/2023
1	Hypercalciuria 12/2022
1	Fatty Liver 07/2022
1	Viremia 01/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2022
1	Disease Progression 01/2022
1	Nephrolithiasis 09/2021
1	Hepatitis 06/2021
1	Chronic Hepatitis (Chronic Active Hepatitis) 05/2021
1	Chronic Hepatitis C 05/2021
1	Inflammation (Inflammations) 01/2021
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021
1	Virus Diseases (Viral Diseases) 10/2016
1	Genomic Instability 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2015

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 12/2024 - 10/2016
9	InterferonsIBA 03/2022 - 01/2016
8	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2015
6	Hepatitis B e AntigensIBA 06/2021 - 01/2016
5	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
3	Sorafenib (BAY 43-9006)FDA Link 11/2022 - 01/2021
3	AntigensIBA 01/2022 - 01/2016
3	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2019
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2016
3	elbasvirIBA 10/2021 - 01/2020
3	grazoprevirIBA 10/2021 - 01/2020
3	B-Cell Activating FactorIBA 06/2021 - 05/2020
2	DNA (Deoxyribonucleic Acid)IBA 07/2023 - 01/2022
2	Calcium OxalateIBA 12/2022 - 09/2021
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 07/2022 - 06/2021
2	Circular DNAIBA 01/2022 - 01/2017
2	CytokinesIBA 06/2021 - 06/2021
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2015 - 01/2015
1	Dihydrotachysterol (AT 10)IBA 03/2024
1	16S Ribosomal RNAIBA 02/2024
1	OligosaccharidesIBA 07/2023
1	PrebioticsIBA 07/2023
1	maltodextrinIBA 07/2023
1	ChitosanIBA 07/2023
1	Uremic ToxinsIBA 07/2023
1	Nucleic AcidsIBA 07/2023
1	Volatile Fatty AcidsIBA 01/2023
1	Long Noncoding RNAIBA 07/2022
1	oligonolIBA 07/2022
1	PolyphenolsIBA 07/2022
1	TriazolesIBA 04/2022
1	GraphiteIBA 01/2022
1	BenzophenonesIBA 01/2022
1	Protons (Proton)IBA 01/2022
1	XanthonesIBA 01/2022
1	Cathepsin DIBA 01/2022
1	Calcitriol Receptors (Calcitriol Receptor)IBA 09/2021
1	Cell-Free Nucleic AcidsIBA 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	B-Cell Maturation AntigenIBA 05/2020
1	Cyclophilins (Cyclophilin)IBA 05/2020
1	LigandsIBA 05/2020
1	B-Cell Activation Factor ReceptorIBA 05/2020
1	Taurocholic Acid (Sodium Taurocholate)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Carrier Proteins (Binding Protein)IBA 10/2018
1	wisteria lectinIBA 10/2018
1	Fetal Proteins (Fetoprotein)IBA 10/2018
1	Vitamin D FDA LinkGeneric 01/2017
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016
1	Interferon-gamma (Interferon, gamma)IBA 01/2016
1	OsteopontinIBA 01/2015
1	STAT4 Transcription FactorIBA 01/2015
1	AflatoxinsIBA 01/2015

Therapy/Procedure

9	Therapeutics 02/2024 - 10/2016
1	Drug Therapy (Chemotherapy) 04/2022
1	Renal Dialysis (Hemodialysis) 01/2022
1	Electrodes (Electrode) 01/2022
1	Aftercare (After-Treatment) 10/2016